Steve Miller - 13 Aug 2021 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Operating Officer
Signature
/s/ Steve Miller
Issuer symbol
CPRX
Transactions as of
13 Aug 2021
Net transactions value
-$46,616
Form type
4
Filing time
17 Aug 2021, 16:51:11 UTC
Next filing
26 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $202,800 +65,000 +9.6% $3.12* 742,687 13 Aug 2021 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $249,416 -40,963 -5.5% $6.09 701,724 13 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Award $0 -65,000 -4.1% $0.000000 1,525,000 13 Aug 2021 Common Stock 65,000 $3.12 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover exercise price of options and tax withholding requirements.
F2 Options vested in three annual tranches beginning on August 28, 2015.